National Health Investors Inc.

NHI | NYSE

Price Alert Chart Builder DCF Calculator

$67.87

+$0.07 (+0.10%)

At close: Sep 21, 2026, 4:00 PM ET

$67.87

$0 (0.00%)

After-hours: Sep 21, 2026, 5:55 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $3.29B

Enterprise Value $4.54B

Beta 0.55

Average Volume 536.22K

Shares Outstanding (Diluted) 48.5M

Shares Change YoY 3.58%

Institutional Ownership 71.50%

Exchange NYSE

ISIN US63633D1046

Price Performance

Price Change 1M -7.8%

Price Change 3M -7.1%

Price Change 6M -18.4%

Price Change YTD -11.7%

Price Change 1Y -13.3%

Price Change 3Y 32.3%

Price Change 5Y 21.2%

1M CAGR (ann.) -9.9%

1Y CAGR (ann.) -10.2%

5Y CAGR (ann.) 9.0%

All-Time CAGR 10.4%

Valuation

PE Ratio 19.62

Forward PE 22.42

PEG Ratio 1.99

Forward PEG -1.04

PS Ratio 7.59

Forward PS 11.80

PB Ratio 2.09

P/FCF Ratio 13.96

P/Adj. FCF Ratio 14.23

P/OCF Ratio 13.10

EV/Sales 10.48

EV/EBIT 20.34

EV/EBITDA 14.38

EV/FCF 19.28

Earnings Yield 5.1%

FCF Yield 7.2%

Adj. FCF Yield 7.0%

Financial Health

Net Debt $1.25B

Total Debt $1.28B

Cash & Short-Term Investments $30.39M

Total Assets $2.96B

Current Ratio 0.59

Quick Ratio 0.59

Debt / Equity Ratio 0.82

Debt / EBITDA 4.06

Debt / FCF 5.45

OCF / Debt 0.20

Interest Coverage 4.46

Altman Z-Score 1.55

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 64.7%

Operating Profit Margin 45.5%

EBITDA Margin 72.9%

Net Profit Margin 38.5%

FCF Margin 54.4%

Adj. FCF Margin 53.3%

SBC / Revenue 1.1%

SBC Impact (per share) -1.9%

Returns

Return on Assets 5.6%

Return on Equity 11.0%

Return on Invested Capital 6.9%

Return on Capital Employed 8.1%

Return on Tangible Assets 5.6%

Historical Growth (CAGR)

Revenue CAGR 3Y 12.2%

Revenue CAGR 5Y 6.2%

Revenue CAGR 10Y 6.2%

EPS CAGR 3Y 21.7%

EPS CAGR 5Y 0.3%

EPS CAGR 10Y -2.2%

FCF CAGR 3Y 12.2%

FCF CAGR 5Y 1.3%

FCF CAGR 10Y 20.0%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 19

EPS Growth Next 3Y -0.7%

Revenue Growth Next 3Y -11.3%

Earnings Date Nov 4, 2026

EPS Estimate (next Q) $1.16

EPS Growth Est (next Q) 68.1%

Revenue Est (next Q) $68.55M

Revenue Growth Est (next Q) 10.2%

Fair Value Estimates

Graham Number $50.44

Graham Upside -25.7%

Lynch Fair Value $17.30

Lynch Upside -74.5%

Price Target $79.40

Price Target Upside 17.0%

Cash Flow

Operating Cash Flow $250.87M

Free Cash Flow $235.71M

Adj. Free Cash Flow $231.11M

FCF Per Share $4.87

OCF Per Share $5.18

OCF/S Ratio 57.9%

Income Statement

Revenue $433.57M

Gross Profit $280.4M

Operating Income $197.04M

EBITDA $316M

Net Income $166.8M

EPS (Diluted) $3.46

Revenue / Employee $13.55M

Profit / Employee $5.21M

Employees 32

Dividends

Annual Dividend $3.68

Dividend Yield 5.42%

Payout Ratio 106.4%

FCF Payout Ratio 74.5%

Adj. FCF Payout Ratio 76.0%

Dividend Growth (YoY) 2.2%

Pay Frequency Quarterly

Ex-Dividend Date Sep 29, 2026